Symptom management in amyotrophic lateral sclerosis: We can do better
- PMID: 28681465
- PMCID: PMC5749258
- DOI: 10.1002/mus.25740
Symptom management in amyotrophic lateral sclerosis: We can do better
Comment on
-
Improving symptom management for people with amyotrophic lateral sclerosis.Muscle Nerve. 2018 Jan;57(1):20-24. doi: 10.1002/mus.25712. Epub 2017 Jul 1. Muscle Nerve. 2018. PMID: 28561886
References
-
- Lacomblez L, Bensimon G, Leigh PN, Guillet P, Meininger V. Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II. Lancet. 1996;347:1425–1431. - PubMed
-
- Charcot JM, J A. Deux cas d'atrophie musculaire progressive avec lesions de la substance grise et des faisceaux antero-lateraux de la moelle epiniere. Arch Physiol Neurol Pathol. 1869;2:744–754.
-
- Miller RG, et al. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2009;73:1227–1233. doi: 10.1212/WNL.0b013e3181bc01a4. - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
